This page contains exclusive content for the member of the following sections: TTS, TID. Log in to view.
Presenter: Ban Hock, Tan, , Singapore
Because much is already known about MRSA and VRE in transplant recipients, this talk will focus on carbepenem-resistant Enterobacteriaceae (CRE) and (time permitting) other extremely drug-resistant (XDR) gram-negatives. Published experience in the treatment of serious CRE infections suggests that antibiotic combinations may be associated with improved outcomes, but a strict analysis of these non-randomized studies has categorized them as “low quality” evidence. In addition to these data, the talk will also touch on the in vitro data (promising!), the role that newer agents such as ceftazidime-avibactam could play (promising but limited), and the small but increasing number of publications hinting at the value of mandatory screening.
By viewing the material on this site you understand and accept that: